Rehabilitative Impacts of a Robotic Knee-Ankle-Foot Orthosis

Summary

We are studying a new robot assisted walking technology for children and adolscents!

The Agilik is a robotic orthosis that can help people with knee-extension disorders walk.

We are interested in understanding how the Agilik might help people.

Participants will train with the Agilik at the Alberta Children's Hospital over a period of time to meet their training goals.

Participants will complete assessments, surveys, and interviews to help us learn about the impact of the Agilik.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 5 to 25

Inclusion criteria:

To be eligible for this study you must meet the following requirements:
1) At least 5 years of age
2) Presence of a condition causing knee-extension difficulties
3) Willing to train with the Agilik at the Alberta Children's Hospital
4) Be between 112 and 180cm tall

Exclusion criteria:

The exclusion criteria for this study is set to ensure use of the Agilik is appropriate for the participants. If any of the following are applicable to you, you cannot participate in this study:
1) Inability to self-initiate gait
2) Body mass greater than 125kg
3) Height greater than 1.83m
4) Any of the following conditions:
a) Medical condition or recent surgery requiring lower extremity immobilization
b) Medical condition requiring physical activity restrictions
c) Pain or symptomatic hypotension while standing
d) Flexion contracture of more than 10 degrees in the knee or hip
e) Moderate to severe spasticity

Participate

Fill out the following form if you want to participate in this research

Method of contact

Collection of personal information
Your personal information is collected under the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If you have any questions about the collection or use of this information, please visit our Access to Information page.

Additional information

Contact information

Please reach out to the PONI lab at poni.lab@ucalgary.ca or by phone at (403)955-5528

Principal investigator:

Elizabeth Condliffe

Clinical trial:

No

REB-ID:

REB25-0662